Skip to main content
. 2025 Mar 17;24:88. doi: 10.1186/s12936-025-05299-5

Table 2.

Seroconversion Rates after Two Immunizations (immunogenicity population)

Investigational product administered by DVI on days 1 and 6 or days 1 and 8 PfCSP IgG ELISA PfCSP IgM ELISA
Number positive/number tested (percent)
9 × 105 PfSPZ of PfSPZ Vaccine 22/23 (95.7%) 22/23 (95.7%)
Normal saline 0/7 0/7